Symrise stock holds steady as 2025 results frame the outlook

Symrise stock remains tied to its latest reported full-year numbers: revenue reached EUR 5.0 billion in 2025, adjusted EBITDA margin was 21.3%, and free cash flow came to EUR 545 million. The companys annual report and investor materials are the only evidenced basis here, so the focus is on those dated figures and what they imply for the shares.

EUR 5.0 billion in 2025

Symrise reported EUR 5.0 billion in revenue for fiscal 2025, alongside adjusted EBITDA of EUR 1.1 billion and an adjusted EBITDA margin of 21.3%. Those figures set the operating frame for Symrise stock because margin quality matters as much as sales scale in a consumer ingredients group.

The comparison that stands out is the margin: 21.3% in 2025 versus 20.8% in 2024, according to the companys investor reporting. Free cash flow also improved to EUR 545 million in 2025 from EUR 471 million in 2024, which gives the balance sheet and capital return discussion more room.

Cash flow improved

Adjusted net income was EUR 368 million in 2025, up from EUR 347 million in 2024, while net debt-to-EBITDA remained at 3.1x at year-end 2025. That combination is useful for the stock because it links profitability, cash generation, and leverage in one reported set of numbers.

For investors, the most relevant question is not whether Symrise has a growth story, but whether the 2025 pace can be repeated without giving up margin. The latest reported figures show a business that still generated EUR 545 million in free cash flow even while investing for expansion.

Pet food and flavors

Symrise describes its work across flavors, nutrition, and pet food solutions, and those categories still define the revenue mix behind the 2025 numbers. Pet food and beverages are among the areas that tend to shape customer demand and pricing discipline, which is why the segment backdrop matters for the shares.

The product lens is broader than a single brand item, but the companys consumer-facing ingredient portfolio remains the practical lens for investors. In a business like this, reported margin and cash conversion are the clearest signals of how well the portfolio is being managed.

Market value matters

Symrise stock closes this note without a dated live price, so the more reliable anchor is the companys reported 2025 operating base: EUR 5.0 billion revenue, EUR 1.1 billion adjusted EBITDA, and EUR 545 million free cash flow. Those figures remain the cleanest factual reference point for assessing the stock until the next scheduled report.